Constipation Newswire

Constipation Newswire

Comprehensive Real-Time News Feed for Constipation.

Results 1 - 20 of 272 in Constipation

  1. Mom's Constipation Turns Into $30 Million Cult JuggernautRead the original story w/Photo

    Wednesday Aug 24 | Entrepreneur Magazine

    "Now everyone is like, 'Why didn't I think of that?'" said Bobby Edwards, the 41-year-old creator and CEO of Squatty Potty. "I have proven a lot of people wrong, and it's felt really good."

    Comment?

  2. Navigating life changeRead the original story w/Photo

    Saturday Aug 20 | Examiner

    ... his mental illness was initially diagnosed as biological, and over time manifested itself through symptoms of constipation, tonsillitis and losing the ability to walk. "They (my parents) eventually found me there crying and they asked me what was ...

    Comment?

  3. Doctor warns most detox tea users have no idea they can cause heart and bowel problemsRead the original story w/Photo

    Thursday Aug 18 | Daily Mail

    ... to remove laxatives from teatoxes. Because while senna is usually safe when used for a few days to treat constipation, research and clinical findings show that longer-term use can cause serious damage to the body. The US National Library of Medicine ...

    Comment?

  4. Global Polyethylene Glycol Market 2016: Industry Demand, Segment, Statistics and Research to 2022Read the original story w/Photo

    Wednesday Aug 17 | SBWire

    ... care, industrial and others. PEG is largely used in various areas of medical industries including solvents, constipation treatments, tablet fillers, ointments, delivery liquid for medications etc. Geographically, the market is segmented into North ...

    Comment?

  5. Incremental Progress At Nektar TherapeuticsRead the original story w/Photo

    Monday Aug 15 | Seeking Alpha

    ... AZN ) were going to blow the doors off with the initial launch of Movantik, an oral drug for opioid-induced constipation. This is a condition where the status quo is to give patients conventional over-the-counter treatments like senna, docusate, ...

    Comment?

  6. Laxatives help slim?Read the original story w/Photo

    Friday Aug 12 | Fox News

    ... it's easier to use the bathroom), and enemas (which involve inserting fluid into the rectum, usually to relieve constipation). If you try to use laxatives for weight loss, you may see the number on the scale go down, but it's deceiving, women's ...

    Comment?

  7. Lessons From a 4-Day Experiment With Laxative TeasRead the original story w/Photo

    Wednesday Aug 10 | New York Magazine

    ... a burrito-rewards program, my body began retaliating. Things got ... slower . Having only ever referred to constipation as a punch line, I first devoted lucrative amounts of time trying to convince my gynecologist I had stomach cancer. Too young to ...

    Comment?

  8. Ardelyx Inc. (ARDX) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPSRead the original story w/Photo

    Monday Aug 8 | AmericanBankingNews.com

    ... product candidate, tenapanor, which in clinical studies has demonstrated the ability to improve the symptoms of constipation-predominant irritable bowel syndrome (IBS-C) and to reduce the absorption of both dietary sodium and phosphorus. Receive ...

    Comment?

  9. Valeant Turns From Buyer to Seller as Debt Repayments LoomRead the original story

    Monday Aug 8 | The Washington Post

    ... sales or offers for some small assets, according to people familiar with the situation. These may include its constipation treatment Relistor, which could be valued at $400 million to $500 million, and dermatology units Obagi Medical Products and ...

    Comment?

  10. Valeant's Relistor Attracts Interest From Rivals, Sale Could Bring In $400-$500 MillionRead the original story

    Sunday Aug 7 | BioSpace

    Valeant Pharmaceuticals International Inc.'s Relistor drug has attracted interest from other companies as the beleaguered Canadian firm works to reduce its debt load, people familiar with the matter said. A potential sale could value the constipation treatment at $400 million to $500 million, the people said, asking not to be identified because the deliberations are private.

    Comment?

  11. Valeant's Relistor Said to Draw Interest of Potential BuyersRead the original story

    Sunday Aug 7 | The Washington Post

    Valeant Pharmaceuticals International Inc.'s Relistor drug has attracted interest from other companies as the beleaguered Canadian firm works to reduce its debt load, people familiar with the matter said. A potential sale could value the constipation treatment at $400 million to $500 million, the people said, asking not to be identified because the deliberations are private.

    Comment?

  12. Ardelyx Inc. (ARDX) Stake Boosted by JPMorgan Chase & Co.Read the original story w/Photo

    Sunday Aug 7 | Daily Political

    ... product candidate, tenapanor, which in clinical studies has demonstrated the ability to improve the symptoms of constipation-predominant irritable bowel syndrome (IBS-C) and to reduce the absorption of both dietary sodium and phosphorus. Want to see ...

    Comment?

  13. Valeant's constipation drug draws interest of potential buyers, sources sayRead the original story w/Photo

    Friday Aug 5 | The Globe and Mail

    ... firm works to reduce its debt load, people familiar with the matter said. A potential sale could value the constipation treatment at $400-million to $500-million, the people said, asking not to be identified because the deliberations are private. ...

    Comment?

  14. Ardelyx Inc. (ARDX) to Release Earnings on MondayRead the original story w/Photo

    Friday Aug 5 | AmericanBankingNews.com

    ... product candidate, tenapanor, which in clinical studies has demonstrated the ability to improve the symptoms of constipation-predominant irritable bowel syndrome (IBS-C) and to reduce the absorption of both dietary sodium and phosphorus. Receive ...

    Comment?

  15. Iowa businessman collects old pharmaceutical bottlesRead the original story w/Photo

    Sunday Jul 31 | News Times

    ... of cough drops. On the label of Dr. Edward's Dandelion pills, the product was promoted as a "treatment for constipation, stomach, liver, kidneys and bowels." Hollister's Golden Nugget Tablets treated constipation. In 1906, the FDA outlawed the word ...

    Comment?

  16. cholestyramine, Questran, Questran LightRead the original story w/Photo

    Friday Jul 29 | MedicineNet

    ... of leflunomide ( Arava ). Long-term use of cholestyramine may cause a deficiency of vitamin A , D, E, and K. Constipation can be an important side effect of cholestyramine, perhaps because the presence of free bile acids in the intestine helps ...

    Comment?

  17. Nektar: Does It Finally Have The Midas Touch?Read the original story w/Photo

    Friday Jul 29 | Seeking Alpha

    ... slides delineating ample information about the status of each product. Movantik is a drug designed for treating constipation caused by prescription pain medicines used by adults with chronic pain, not caused by cancer. This condition creates major ...

    Comment?

  18. What No One Talks About When They Talk About Summer CampRead the original story w/Photo

    Friday Jul 29 | SFGate

    ... being super stressed about not pooping, but I was scared of the health center, so suffered in silence... Constipation is a common thing at camp. And it's a struggle ." And when I asked her if the counselors get briefed on healthy pooping practices, ...

    Comment?

  19. Letter: Constipation advice for allRead the original story w/Photo

    Friday Jul 29 | Penarth Times

    SHOCKING figures recently released show that Britons' embarrassment over their bowel issues costs the NHS A 145 million a year. The YouGov report shows that in 2014/15, 133 people per day were treated for constipation as an unplanned emergency admission, meaning they were forced to go to A&E for a condition that's easily treated at home.

    Comment?

  20. Progenics Receives $50 Mln Milestone Payment After Opioid-induced Constipation Drug ApprovalRead the original story w/Photo

    Jul 26, 2016 | Fox News

    Progenics Pharmaceuticals Inc. said Tuesday it received a $50 million milestone payment after its opioid-induced constipation drug Relistor was approved last week. The payment was from Valeant Pharmaceuticals International Inc. , a global collaborative partner of Progenics.

    Comment?